| Outcome Measures: |
Primary: Change in liver fat content, Difference in the change of liver fat content between the two groups at week 52 from the baseline as measured by MRI-PDFF, week 52 | Secondary: Remission of steatosis, Remission of steatosis (defined as MRI-PDFF \< 5%) at week 52, week 52|Change of liver fat content, Difference in the change of liver fat content between the two groups at week 26 and 52 from the baseline (CAP measured by transient elastography), week 26 and 52|Changes of alanine aminotransferase (ALT), Changes of ALT at week 52, week 52|Changes of aspartate aminotransferase (AST), Changes of AST at week 52, week 52|Changes of alkaline phosphatase (ALP), Changes of ALP at week 52, week 52|Changes of gamma glutamyl transferase (GGT), Changes of GGT at week 52, week 52|Changes of fasting glucose, Changes of fasting glucose at week 52, week 52|Changes of haemoglobin A1c (HbA1c), Changes of HbA1c at week 52, week 52|Changes of total cholesterol, Changes of total cholesterol at week 52, week 52|Changes of low density lipoprotein (LDL), Changes of LDL at week 52, week 52|Changes of high density lipoprotein (HDL), Changes of HDL at week 52, week 52|Changes of body weight, Changes of body weight at week 52, week 52|Changes of height, Changes of height at week 52, week 52|Changes of body mass index (BMI), Changes of BMI at week 52, week 52|Changes of waist circumference, Changes of waist circumference at week 52, week 52|Changes of systolic blood pressure, Changes of systolic blood pressure at week 52, week 52|Changes of diastolic blood pressure, Changes of diastolic blood pressure at week 52, week 52
|
